Regions Financial Corp Vericel Corp Transaction History

Regions Financial Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 23, 2024	BUY	$32.52 - $52.33 $138,470 - $222,821	4,258 New	4,258 $221,000
Q2 2023 Aug 09, 2023	BUY	$29.0 - $38.37 $156,368 - $206,891	5,392 New	5,392 $202,000
Q2 2019 Jul 19, 2019	SELL	$15.01 - $18.89 $37,525 - $47,225	-2,500 Closed	0 $0
Q1 2019 Apr 19, 2019	BUY	$16.23 - $20.29 $9,705 - $12,133	598 Added 31.44%	2,500 $44,000
Q4 2018 Jan 28, 2019	BUY	$10.77 - $18.44 $20,484 - $35,072	1,902 New	1,902 $33,000

279

48.7M

91.8K

23.2K

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.76B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

Get notified when there are updates to the investment portfolio of Regions Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Regions Financial Corp with notifications on news.